Contraception Archives - MPR

Contraception

Combined Oral Contraceptive Pill, Metformin Assessed for PCOS Management

The use of combined oral contraceptive pills (COCP) and metformin, either as monotherapy or combined, was evaluated for the treatment of polycystic ovary syndrome (PCOS) in a recent systematic review published in the journal Clinical Endocrinology. Study authors systematically searched electronic databases for applicable randomized controlled trials that assessed these therapies for the management of…

NDA for Twirla Contraceptive Patch Resubmitted to FDA

Agile Therapeutics has resubmitted to the Food and Drug Administration (FDA) the New Drug Application (NDA) for its product, Twirla, an investigational low-dose combined hormonal contraceptive patch (AG200-15). Based on the results from a comparative wear study, the resubmitted NDA will address the FDA’s questions on in vivo adhesion, additional information on the Company’s manufacturing…

Oral Contraceptive Product Recalled Due to Packaging Error

Apotex announced a voluntary recall of 4 lots of Drospirenone and Ethinyl Estradiol Tablets 3mg/0.03mg due to the possibility of defective blisters with incorrect tablet arrangements and/or empty blister pockets. Drospirenone and Ethinyl Estradiol is an estrogen/progestin combination oral contraceptive indicated for the prevention of pregnancy. The tablets in the inner carton are arranged as…